halofantrine: Clinical Trials

15 trials of halofantrine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Completed 11, Unknown 2, Not yet recruiting 1, Recruiting 1

Follow halofantrine: new trials by email Literature Review of halofantrine trials Research Report on halofantrine

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RSV Vaccination to Reduce Recurrent AECOPD
RSV vaccination (Arexvy, GlaxoSmithKline) - COPD, RSV
Phase 4Not yet recruitingChinese University of Hong Kong3202027-07-012026-04-13
Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline, Cipralex (escitalopram) - Major Depressive Disorder (MDD)
Phase 4RecruitingMedical University of Vienna1202022-12-012024-11-05
Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy.
Voltaren Ophtha 1 mg/ml, GSK, Monopex 1 mg/ml, Théa - Glaucoma
Phase 4UnknownCopenhagen University Hospital, Rigshospitalet702019-08-012022-10-26
Hypertonic Saline Enhances The Field of View of Clinicians and Ease of Procedures
Intranasal solutions application were done including one solution for per patient before nasoendoscopy procedure according to randomization - Nasopharyngeal Diseases
Phase 4CompletedSelcuk University2002016-02-012020-01-02
A Study of the Interaction Between BCG And MenC Immunisation: BAM
BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix® - BCG Infection, Reaction - Vaccine
Phase 4CompletedUniversity of Oxford282014-06-202018-10-18
Atazanavir/r + Lamivudine Dual Therapy
Atazanavir, ritonavir, lamivudine - Human Immunodeficiency Virus
Phase 4CompletedCatholic University of the Sacred Heart2662014-04-012019-07-24
Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication
Lamivudine 100mg once daily; or Entecavir 0.5mg once daily. - Hepatocellular Carcinoma
Phase 4UnknownSun Yat-sen University2002013-07-012013-07-23
Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old
Prepandrix™, Fluarix™ - Influenza
Phase 4CompletedGlaxoSmithKline1312012-12-052018-09-07
Understanding the Immune Response to Two Different Meningitis Vaccines
MenACWY-CRM conjugate vaccine (Menveo, Novartis), MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis), 1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) - Meningitis, Meningococcal Disease
Phase 4CompletedUniversity of Oxford202012-12-012026-05-04
Effect of HPV Vaccination on Women Aged 25 Years
Cervarix®, GlaxoSmithKline - Cervical Cancer
Phase 4CompletedCancer Prevention and Research Institute, Italy8322010-04-012014-11-20
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Adjuvanted influenza A(H1N1) vaccines - HIV Infection, Rheumatic Disease
Phase 4CompletedUniversity Hospital, Geneva11412009-11-012010-03-01
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium) - Hepatitis B, Immune Response
Phase 4CompletedHui Zhuang20402009-09-012013-05-24
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
Human papilloma virus vaccine (cervarix) - Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus
Phase 4CompletedN.M. Wulffraat1352009-02-012017-11-13
Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression
ECT Mecta 5000M, Methohexitone, Suxamethonium - Depression
Phase 4CompletedSt Patrick's Hospital, Ireland1382008-05-012018-11-14
Physical Exercise Versus Rosiglitazone in CAD and Prediabetes
rosiglitazone, physical exercise, control - Impaired Glucose Tolerance
Phase 4CompletedUniversity of Leipzig452004-01-012010-02-02

Conditions studied

Depression (2)  ·  HIV Infections (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Arthritis, Juvenile (1)  ·  Carcinoma, Hepatocellular (1)  ·  Depressive Disorder, Major (1)  ·  Dermatomyositis (1)  ·  Eye Diseases (1)  ·  Glaucoma (1)  ·  Glucose Intolerance (1)  ·  Hepatitis B (1)  ·  Influenza, Human (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Meningitis (1)  ·  Meningococcal Infections (1)

Sponsors

University of Oxford (2)  ·  Cancer Prevention and Research Institute, Italy (1)  ·  Catholic University of the Sacred Heart (1)  ·  Chinese University of Hong Kong (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  GlaxoSmithKline (1)  ·  Hui Zhuang (1)  ·  Medical University of Vienna (1)  ·  N.M. Wulffraat (1)  ·  Selcuk University (1)  ·  St Patrick's Hospital, Ireland (1)  ·  Sun Yat-sen University (1)  ·  University Hospital, Geneva (1)  ·  University of Leipzig (1)

Countries

China (2)  ·  Italy (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Denmark (1)  ·  Hong Kong (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

Andrew J Pollard, BA, MBBS, FRCPCH, PhD (1)  ·  Daniella Bach-Holm, MD, Ph.D. (1)  ·  Declan M McLoughlin, PhD (1)  ·  Fiona van der KLis, MD, PhD (1)  ·  Francesca M Carozzi, PhD (1)  ·  Guy Berbers, PhD (1)  ·  Mauro MM Moroni, MD (1)  ·  Nico M Wulffraat, MD, PhD (1)  ·  Ozkan Onal, Professor (1)  ·  Pierluigi PZ Zoccolotti, MD (1)  ·  Roberto RC Cauda, MD (1)  ·  Stafano SV Vella, MD (1)  ·  Xiang-Ming Lao, MD (1)  ·  Xiao-Jun Lin, MD (1)

Results publications

PMID 17265499, PMID 17284544, PMID 21384334, PMID 21419775, PMID 21422117, PMID 22228003, PMID 22848378, PMID 23571176, PMID 23723319, PMID 25418873, PMID 25910919, PMID 27728850, PMID 28093483, PMID 29668978, PMID 34752484, PMID 36602718, PMID 38676734, PMID 42264114

NIH funding

2019 (1)